Medtronic PLC vs MKS Instruments — how do they compare? Medtronic PLC trades at $88.02 (market cap $112.24B), while MKS Instruments trades at $262.73 (market cap $17.61B). The key difference: Medtronic PLC is far larger — about 6.4× MKS Instruments's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and MKS Instruments for 7 Days on average.
| MDT | MKSI | |
|---|---|---|
Market Cap | $112.24B | $17.61B |
Volume | 105,663,236 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $105.35 | $444.80 |
52-Week Low | $73.75 | $121.26 |
Typical Hold Time | 63 Days | 7 Days |
Enterprise Value | $131.58B | $21.18B |
Dividend Yield | 3.28% | 0.38% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →